Project Details
Description
ZMapp EAP: An Expanded Access Treatment Protocol for ZMapp for Patients with Zaire ebolavirus Disease (EVD) or Zaire ebolavirus exposure
| Status | Finished |
|---|---|
| Effective start/end date | 6/27/19 → 1/7/21 |
Funding
- MAPP BIOPHARMACEUTICAL, INC.
- US DEPT OF HEALTH & HUMAN SERVICES PHE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.